FDA Inspection 1276700 — Implant Direct Sybron Manufacturing LLC

Implant Direct Sybron Manufacturing LLC — FEI 3001617766

The FDA completed an inspection of Implant Direct Sybron Manufacturing LLC on July 24, 2025 in Westlake Village, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 24, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Westlake Village, CA (United States)